If you may be in danger, call or text 988. Call 911 for emergencies. More crisis resources
For education, not medical advice. Always talk with your own doctor or prescriber about your treatment.

Psychiatric pharmacy panel

Board-certified psychiatric pharmacists (BCPP) reviewing pharmacokinetics, interactions, and dosing tables.

Scope

The CYP450 interaction reference, half-life quick reference, renal and hepatic dosing guides, dose equivalence tables (CPZ, diazepam), taper planner, discontinuation-syndromes guide, and every interaction page.

Pages owned by this panel

23 pages fall in the panel's review scope. A specialist joining the panel reviews some or all of these; the specific pages a reviewer approves are listed on that reviewer's profile.

Current members

This panel currently has 1 named seat open. No specialist reviewer has joined yet.

A reviewer's name only appears on this page after they have (a) agreed in writing to participate and (b) reviewed and approved at least one page in the scope above. We do not pad panels with unaffiliated names.

Join this panel

If you are a board-certified specialist in psychiatric pharmacy and would like to review pages in the scope above, see the contribute page for the full application process, or email [email protected] with the subject line "Psychiatric pharmacy panel: application."

Reviewers receive: a public profile page at /reviewers/<your-slug>/, named credit on every page they review, a shareable badge for their institutional bio or CV, and a canonical inbound link from PsychiatryRx to their broader academic identity. Reviewers do not receive compensation, referral revenue, or any commercial relationship with the site.